Maropitant 马罗皮坦,99.79%
产品编号:Bellancom-10053| CAS NO:147116-67-4| 分子式:C32H40N2O| 分子量:468.67
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Maropitant 马罗皮坦
| 产品介绍 | Maropitant 是一种选择性的具有口服活性的神经激肽 (NK1 ) 受体拮抗剂。Maropitant 通过阻止催吐中心与化学感受器触发区 (CRTZ) 中 P 物质的结合而起作用。Maropitant 在预防呕吐方面非常有效。 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | Maropitant is a selective and orally active neurokinin (NK1) receptor antagonist. Maropitant acts by blocking the binding of substance P within the emetic center and the chemoreceptor trigger zone (CRTZ). Maropitant is highly effective in preventing vomiting.  | ||||||||||||||||
| 体外研究 | |||||||||||||||||
| 体内研究 |                                         
                                        
                                             Treatment with 1 mg/kg Maropitant citrate, significantly reduces the size of ulcerative dermatitis (UD) lesions in mice. Intravenous Maropitant decreases MAC by 16%. In contrast, epidural administration of either saline or Maropitant does not change the MAC (2.17% and 1.92 %, respectively). 西域 has not independently confirmed the accuracy of these methods. They are for reference only.  | ||||||||||||||||
| 体内研究 |                                         
                                        
                                             Treatment with 1 mg/kg Maropitant citrate, significantly reduces the size of ulcerative dermatitis (UD) lesions in mice. Intravenous Maropitant decreases MAC by 16%. In contrast, epidural administration of either saline or Maropitant does not change the MAC (2.17% and 1.92 %, respectively). 西域 has not independently confirmed the accuracy of these methods. They are for reference only.  | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| 溶解性数据 | 
                                        
                                             In Vitro:  
                                            DMSO : 33.33 mg/mL (71.12 mM; Need ultrasonic) 配制储备液 
                                                
 
 
                                                    *
                                                     
                                            
                                        
                                        
                                            请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 
                                            请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: 
                                                    ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
                                                        以下溶剂前显示的百 
 *以上所有助溶剂都可在 西域 网站选购。 
                                            
                                        
                                     | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere.  | ||||||||||||||||
| 储存方式 | 
                                
  | ||||||||||||||||
| 参考文献 | 
  | 
                            
                                    
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                        
 
 
 
 
浙公网安备 33010802013016号